NCT00005121View on ClinicalTrials.gov

Framingham Heart Study

CompletedOBSERVATIONAL
Timeline

Start Date

July 31, 1948

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Cardiovascular DiseasesHeart DiseasesCoronary DiseaseCerebrovascular AccidentHypertensionHeart Failure, CongestivePeripheral Vascular DiseasesArterial Occlusive DiseasesAtherosclerosisHeart Failure
All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00005121 - Framingham Heart Study | Biotech Hunter | Biotech Hunter